C4A and scleroderma: Additionally, the absence of anti-nuclear antibodies (ANA), negative scleroderma-associated antibodies (Scl-70), negative antiphospholipid and cardiolipin antibodies, and normal complement C4 levels effectively excluded other systemic autoimmune and complement-mediated inflammatory diseases.